论文部分内容阅读
将66例糖尿病周围神经病变患者随机分为治疗组32例与对照组34例,两组均基于糖尿病基本治疗,对照组予前列地尔加弥可保治疗,治疗组在对照组基础上加用α-硫辛酸,疗程2周,观察并记录治疗前后患者症状、体征和肌电图。结果:两组神经传导速度均改善,以治疗组改善更明显。两组间疗效相比有统计学意义(P<0.05)。结论:在糖尿病基本治疗基础上,α-硫辛酸联合前列地尔、弥可保治疗糖尿病周围神经病变疗效满意,值得临床推广和应用。
66 patients with diabetic peripheral neuropathy were randomly divided into treatment group 32 cases and control group 34 cases, both groups were based on the basic treatment of diabetes, the control group was treated with alprostadil plus Mi-Pak treatment, the treatment group on the basis of the control group α-lipoic acid for 2 weeks. The symptoms, signs and electromyography before and after treatment were observed and recorded. Results: The nerve conduction velocity was improved in both groups, and the treatment group improved more obviously. The curative effect between the two groups was statistically significant (P <0.05). Conclusion: Based on the basic treatment of diabetes, α-lipoic acid combined with alprostadil and methycobarb is effective in treating diabetic peripheral neuropathy and is worthy of clinical promotion and application.